Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for identification and clustering of Neisseria gonorrhoeae Clinical microbiology and vaccines

BMC Microbiology

Volumn 15, Issue 1, 2015, Pages

  Carannante, Anna ^a   De Carolis, Elena ^b   Vacca, Paola ^a   Vella, Antonietta ^b   Vocale, Caterina ^c   De Francesco, Maria Antonia ^d   Cusini, Marco ^e   Del Re, Simonetta ^f   Dal Conte, Ivano ^f   Cristaudo, Antonio ^g   Ober, Patrizia ^h   Sanguinetti, Maurizio ^b   Stefanelli, Paola ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f AMEDEO DI SAVOIA HOSPITAL   (Italy)

^g SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^h SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Cluster; G1407; MALDI TOF MS; Neisseria gonorrhoeae

Indexed keywords

CEFIXIME; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLUSTER ANALYSIS; CONTROLLED STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MULTIANTIGEN SEQUENCE TYPING; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; NONHUMAN; PHYLOGENETIC TREE; PORB GENE; TBPB GENE; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; EVALUATION STUDY; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; ITALY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; PHENOTYPE; PROCEDURES;

NEISSERIA GONORRHOEAE;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CEFIXIME; CLUSTER ANALYSIS; GENOTYPE; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; PHENOTYPE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84937853640     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-015-0480-y     Document Type: Article

References (36)

1. World Health Organization (WHO). Department of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva, Switzerland: WHO; 2012. http://www.who.int/reproductivehealth/publications/rtis/2008-STI-estimates.pdf.
2. Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr Opin Infect Dis. 2009;22:87-91.
3. Cole MJ, Spiteri G, Chisholm SA, Hoffmann S, Ison CA, Unemo M, et al. Emerging cephalosporin and multidrug-resistant gonorrhea in Europe. Euro Surveill. 2014; 19:pii∈=∈20955. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20955.
4. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55:3538-45.
5. European Centre for Disease Prevention and Control (ECDC). Surveillance report. Response plan to control and manage the threat to multidrug-resistance gonorrhoea in Europe. Stockholm, 2012. ECDC; 2012. http://www.ecdc.europa.eu/en/publications/Publications/1206-ECDC-MDR-gonorrhoea-response-plan.pdf
6. World Health Organization (WHO). Department of Reproductive Health and Research. Global action plan to control the spread and impact of anti-microbial resistance in Neisseria gonorrhoeae. Geneva, Switzerland: WHO; 2012. http://whqlibdoc.who.int/publications/2012/9789241503501-eng.pdf.
7. Carannante A, Renna G, Dal Conte I, Ghisetti V, Matteelli A, Prignano G, et al. Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012. Antimicrob Agents Chemother. 2014;58:5871-76.
8. European Centre for Disease Prevention and Control (ECDC). Surveillance report. Gonococcal antimicrobial susceptibility surveillance in Europe, 2011. Stockholm, 2013. ECDC; 2013. http://www.ecdc.europa.eu/en/publications/publications/gonococcal-antimicrobial-susceptibility-surveillance-27-mar-2013.pdf.
9. Camàra J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolated detected in Catalonia, Spain. J Antimicrob Chemother. 2012;67:1858-60.
10. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime and ceftriaxone resistant N. gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-80.
11. Shimuta K, Unemo M, Nakayama S, Morita-Ishihara T, Dorin M, Kawahata T, et al. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother. 2013;57:5225-32.
12. Starnino S, Suligoi B, Regine V, Bilek N, Stefanelli P, Neisseria gonorrhoeae Italian Study Group, et al. Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: detection of a multiresistant cluster circulating in a heterosexual network. Clin Microbiol Infect. 2008;14:949-54.
13. Carannante A, Prignano G, Cusini M, Matteelli A, Dal Conte I, Ghisetti V, et al. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010. Clin Microbiol Infect. 2012;18:558-64.
14. Jeverica S, Golparian D, Matičič M, Potočnik M, Mlakar B, Unemo M. Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multi-drug-resistant NG-MAST genogroup 1407 clone? J Antimicrob Chemother. 2014;69:1517-25.
15. European Centre for Disease Prevention and Control (ECDC). Technical report. Molecular typing of Neisseria gonorrhoeae. Results from a pilot study 2010-2011. Stockholm, 2012. ECDC; 2012. http://www.ecdc.europa.eu/en/publications/Publications/201211109-Molecular-typing-gonorrhea.pdf.
16. Chisholm SA, Unemo M, Quaye N, Johansson E, Cole MJ, Ison CA, et al. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill. 2013;18:20358-68.
17. Unemo M, Dillon JR. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin Microbiol Rev. 2011;24:447-58.
18. Pandori M, Barry PM, Wu A, Ren A, Whittington WL, Liska S, et al. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother. 2009;53:4032-4.
19. Bizzini A, Greub G. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect. 2010;16:1614-9.
20. Wieser A, Schneider L, Jung J, Schubert S. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review). Appl Microbiol and Biotechnol. 2012;93:965-74.
21. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol. 2012;50:3301-8.
22. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2013;137:1247-54.
23. Ayyadurai S, Flaudrops C, Raoult D, Drancourt M. Rapid identification and typing of Yersinia pestis and other Yersinia species by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. BMC Microbiol. 2010;10:285.
24. Zautner AE, Masanta WO, Tareen AM, Weig M, Lugert R, Groß U, et al. Discrimination of multilocus sequence typing-based Campylobacter jejuni subgroups by MALDI-TOF mass spectrometry. BMC Microbiol. 2013;13:247.
25. Fournier PE, Drancourt M, Colson P, Rolain JM, La Scola B, Raoult D. Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol. 2013;11:574-85.
26. Spiteri G, Cole M, Unemo M, Hoffman S, Ison C, Van de Laar M. The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)-a sentinel approach in the European Union (EU)/European Economic Area (EEA). Sex Transm Infect. 2013;89:16-8.
27. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoints tables for interpretation of MICs and zone diameters, Version 5.0, 2015. Available at: http://www.eucast.org.
28. Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. Phenotypic and genetic characterization oft he 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother. 2009;63:1142-51.
29. Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004;189:1497-505.
30. Spanu T, De Carolis E, Fiori B, Sanguinetti M, D'Inzeo T, Fadda G, et al. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification of bloodstream infection staphylococcal isolates. Clin Microbiol Infect. 2011;17:44-9.
31. Rettinger A, Krupka I, Grünwald K, Dyachenko V, Fingerle V, Konrad R, et al. Leptospira spp. strain identification by MALDI TOF MS is an equivalent tool to 16S rRNA gene sequencing and multi locus sequence typing (MLST). BMC Microbiology. 2012;12:185.
32. Vella A, De Carolis E, Vaccaro L, Posteraro P, Perlin DS, Kostrzewa M, et al. Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis. J Clin Microbiol. 2013;51:2964-69.
33. Bignell C, Unemo M on behalf of the European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24:85-92. http://www.iusti.org/regions/Europe/pdf/2012/Gonorrhoea-2012.pdf.
34. Thakur SD, Levett PN, Horsman GB, R Dillon JA. Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally. Sex Transm Infect. 2014;90:297-302.
35. Goire N, Lahra MM, Chen M, Donovan B, Fairley CK, Guy R, et al. Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. Nat Rev Microbiol. 2014;12:223-9.
36. Spinali S, Van Belkum A, Goering RV, Girard V, Welker M, Van Nuenen, et al. Microbial typing by matrix-assisted laser desorption ionization-tima of flight mass spectrometry: do we need guidance for data interpretation? J Clin Microbiol. 2015;53:760-5.